Advanced Instruments LLC, Norwood, Mass, has appointed Byron Selman as chief executive officer.
Selman comes to Advanced Instruments from Haemonetics Corp, Braintree, Mass, where he served most recently as president of global markets. Prior to Haemonetics, he spent more than 20 years with Pall Corp in various executive level and general management positions. Selman’s career has provided him with a broad range of experience across multiple functional disciplines including sales, marketing, business development, engineering, operations, and general management.
“We are excited to have Byron join Advanced Instruments,” says Craig Majernik, managing director at Windjammer Capital Investors, which acquired the company in October 2016. “His proven leadership abilities and demonstrated record of success position him well to lead the execution of the company’s organic and acquisition growth strategy.”
“Advanced Instruments represents a unique opportunity given its well-respected brand, technical know-how, and channels to market,” says Selman. “I am encouraged by the multiple avenues available to the company to enhance and expand its well-established platform in the clinical diagnostic and biopharmaceutical tools markets.”
Selman holds a bachelor of science degree in mechanical engineering from Case Western Reserve University and a master of business administration degree from the Frank G. Zarb School of Business at Hofstra University.
Selman replaces John Coughlin, who served as CEO of Advanced Instruments for more than 16 years and will continue in his retirement as a nonexecutive member of the board.
For more information, visit Advanced Instruments.